ML161 (aka Parmodulin 2) greatly improves kidney function in a mouse model of diabetic kidney disease

Paul Ornstein, Ph.D. joins as VP of Preclinical Development

Function Therapeutics receives Dept. of Defense award.

U.S. patent #11,130,743 has been granted.

Function Therapeutics, Inc. has incorporated.

Function Therapeutics announces initial Scientific Advisory Board members.